These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19290933)

  • 21. IL-15 renders conventional lymphocytes resistant to suppressive functions of regulatory T cells through activation of the phosphatidylinositol 3-kinase pathway.
    Ben Ahmed M; Belhadj Hmida N; Moes N; Buyse S; Abdeladhim M; Louzir H; Cerf-Bensussan N
    J Immunol; 2009 Jun; 182(11):6763-70. PubMed ID: 19454671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory B cells in autoimmune diseases: how do they work?
    Lemoine S; Morva A; Youinou P; Jamin C
    Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential roles of PI3-Kinase, MAPKs and NF-kappaB on the manipulation of dendritic cell T(h)1/T(h)2 cytokine/chemokine polarizing profile.
    Neves BM; Cruz MT; Francisco V; Garcia-Rodriguez C; Silvestre R; Cordeiro-da-Silva A; Dinis AM; Batista MT; Duarte CB; Lopes MC
    Mol Immunol; 2009 Aug; 46(13):2481-92. PubMed ID: 19520433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.
    Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T
    J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier.
    Li M; Shang DS; Zhao WD; Tian L; Li B; Fang WG; Zhu L; Man SM; Chen YH
    J Immunol; 2009 May; 182(9):5778-88. PubMed ID: 19380826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-G-dependent suppressor cells: Diverse by nature, function, and significance.
    Carosella ED; HoWangYin KY; Favier B; LeMaoult J
    Hum Immunol; 2008 Nov; 69(11):700-7. PubMed ID: 18817832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TIM family proteins and autoimmunity.
    Kane LP
    Autoimmunity; 2007 Sep; 40(6):405-8. PubMed ID: 17729033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of PI-3 kinase for treating respiratory disease: good idea or bad idea?
    Thomas M; Owen C
    Curr Opin Pharmacol; 2008 Jun; 8(3):267-74. PubMed ID: 18394961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PI3K inhibitors in inflammation, autoimmunity and cancer.
    Stark AK; Sriskantharajah S; Hessel EM; Okkenhaug K
    Curr Opin Pharmacol; 2015 Aug; 23():82-91. PubMed ID: 26093105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of T lymphocyte fate decisions by PI3K signaling.
    Murter B; Kane LP
    F1000Res; 2020; 9():. PubMed ID: 33024547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphatidylinositol 3-kinase signaling and immune regulation: insights into disease pathogenesis and clinical implications.
    Nguyen T; Deenick EK; Tangye SG
    Expert Rev Clin Immunol; 2021 Aug; 17(8):905-914. PubMed ID: 34157234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation.
    El Sheikh SS; Domin J; Tomtitchong P; Abel P; Stamp G; Lalani EN
    BMC Clin Pathol; 2003 Oct; 3(1):4. PubMed ID: 14563213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Atypical lymphocytes].
    Kasprzycka E; Zak J; Ratomski K; Wysocka J
    Pol Merkur Lekarski; 2008 May; 24(143):443-5. PubMed ID: 18634392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PI3K signalling in inflammation.
    Hawkins PT; Stephens LR
    Biochim Biophys Acta; 2015 Jun; 1851(6):882-97. PubMed ID: 25514767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.
    So L; Fruman DA
    Biochem J; 2012 Mar; 442(3):465-81. PubMed ID: 22364281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PI3K inhibition in inflammation: Toward tailored therapies for specific diseases.
    Ghigo A; Damilano F; Braccini L; Hirsch E
    Bioessays; 2010 Mar; 32(3):185-196. PubMed ID: 20162662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the potential of myo-inositol in thyroid disease management: focus on thyroid cancer diagnosis and therapy.
    Razavi SA; Kalari M; Haghzad T; Haddadi F; Nasiri S; Hedayati M
    Front Endocrinol (Lausanne); 2024; 15():1418956. PubMed ID: 39329107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Comprehensive Examination of the Role of Epigenetic Factors in Multiple Sclerosis.
    Manna I; De Benedittis S; Porro D
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201606
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.